Logo

Most Medicare beneficiaries may pay more for drugs under the Inflation Reduction Act

Most Medicare beneficiaries may pay more for drugs under the Inflation Reduction Act

Making prescription drugs more affordable was a key goal of the Inflation Reduction Act (IRA). However, most Medicare beneficiaries may end up paying more out of pocket for medicines as Part D plans adjust to the law's new provisions, according to a new white paper from the USC Schaeffer Center for Health Policy & Economics.

👉 Full Story